The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes (Braini-Ex)

This study has been completed.
Sponsor:
Collaborators:
Eli Lilly and Company
Bristol-Myers Squibb
Information provided by (Responsible Party):
RG IJzerman, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01281228
First received: January 20, 2011
Last updated: June 2, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
No publications provided by VU University Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):